Reducing the potential for mistakes with investigational drugs.
作者信息
Grissinger Matthew
出版信息
P T. 2011 Mar;36(3):120-38.
Abstract
摘要
相似文献
1
Reducing the potential for mistakes with investigational drugs.
P T. 2011 Mar;36(3):120-38.
2
A practical approach to assess the hazardous exposure potential of investigational drugs.
Am J Health Syst Pharm. 2020 Apr 27;77(9):697-700. doi: 10.1093/ajhp/zxaa051.
3
What do patients with unmet medical needs want? A qualitative study of patients' views and experiences with expanded access to unapproved, investigational treatments in the Netherlands.
BMC Med Ethics. 2019 Nov 9;20(1):80. doi: 10.1186/s12910-019-0420-8.
4
Effects of pharmacist interventions on reducing prescribing errors of investigational drugs in oncology clinical trials.
J Oncol Pharm Pract. 2020 Jan;26(1):29-35. doi: 10.1177/1078155219834723. Epub 2019 Mar 4.
5
Current good manufacturing practice and investigational new drugs intended for use in clinical trials. Final rule.
Fed Regist. 2008 Jul 15;73(136):40453-63.
6
FDA's proposed regulations to expand access to investigational drugs for treatment use: the status quo in the guise of reform.
Food Drug Law J. 2009;64(1):183-223.
7
Expanded access to investigational drugs for treatment use. Final rule.
Fed Regist. 2009 Aug 13;74(155):40900-45.
8
Investigational drug labeling variability.
Clin Trials. 2019 Apr;16(2):204-213. doi: 10.1177/1740774519828382. Epub 2019 Feb 3.
9
Charging for investigational drugs under an investigational new drug application. Final rule.
Fed Regist. 2009 Aug 13;74(155):40871-900.
10
Investigational drug practices in Michigan hospitals.
Am J Hosp Pharm. 1989 Jul;46(7):1370-5.
引用本文的文献
1
Audit experiences in investigational medicinal product management and errors in clinical trials.
Trials. 2025 Mar 21;26(1):100. doi: 10.1186/s13063-025-08795-w.
2
Medication Safety in Clinical Trials: Role of the Pharmacist in Optimizing Practice, Collaboration, and Education to Reduce Errors.
Yale J Biol Med. 2017 Mar 29;90(1):125-133. eCollection 2017 Mar.
3
Safety risks with investigational drugs: Pharmacy practices and perceptions in the veterans affairs health system.
Ther Adv Drug Saf. 2015 Jun;6(3):103-9. doi: 10.1177/2042098615584924.
Zotero 插件